Clinical Trial Update: A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix [NA]

View source ↗

Summary

The randomized trial comparing cerclage to 17 α-hydroxyprogesterone caproate for short cervix in pregnancy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Insufficiency
• Preterm Birth
• Short Cervix

Drugs mentioned

• 17 α-hydroxyprogesterone caproate (17α-hydroxyprogesterone caproate)
• Cerclage

Snippet

Sponsor: Lehigh Valley Hospital | Conditions: Mid Trimester Cervical Shortening | NA | Status: TERMINATED